
Numglim MF 2mg/500mg Tablet ER
Marketer
Plenum Biotech Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Numglim MF 2mg/500mg Tablet ER
Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Uses of Numglim MF 2mg/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Numglim MF 2mg/500mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Numglim MF 2mg/500mg Extended-Release tablet should be taken with meals.
Common Side effects of Numglim MF 2mg/500mg Tablet ER:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Numglim MF 2mg/500mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Numglim MF 2mg/500mg Extended-Release tablets should be taken with meals.
How Numglim MF 2mg/500mg Tablet ER works:
Numglim MF 2mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Numglim MF 2mg/500mg Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Numglim MF 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Numglim MF 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Numglim MF 2mg/500mg Extended-Release tablets. Dosage modification may be necessary; physician consultation is recommended. Numglim MF 2mg/500mg Extended-Release tablets are contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is advised during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Numglim MF 2mg/500mg Extended-Release tablets. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Numglim MF 2mg/500mg Tablet ER :
Should you forget to take a Numglim MF 2mg/500mg Extended-Release tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Numglim MF 2mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
